Oculis Holding AG (OCS) Total Liabilities (2021 - 2026)

Oculis Holding AG's (OCS) quarterly Total Liabilities came in at $60.5 million in Q1 2026, up 30.84% year-on-year from $46.2 million in Q1 2025, and up 21.13% quarter-over-quarter from $49.9 million in Q4 2025.

Oculis Holding AG (OCS) Total Liabilities (2021 - 2026) Analysis & Trends

Oculis Holding AG's Total Liabilities history runs 6 years deep, the most recent figure standing at $60.5 million for Q1 2026.

  • On a quarterly basis, Total Liabilities rose 30.84% year-over-year to $60.5 million in Q1 2026; TTM through Mar 2026 was $60.5 million, a 30.84% increase from a year earlier, with the FY2025 full-year figure at $48.1 million, down 9.88% from the prior year.
  • Total Liabilities advanced to $60.5 million in Q1 2026 per OCS's latest filing, from $49.9 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $140.2 million in Q4 2022 and bottomed at $19.6 million in Q2 2023.
  • The 5-year median for Total Liabilities is $46.2 million (2025), against an average of $46.1 million.
  • Across the five-year window, Total Liabilities plunged 83.41% in 2023 and surged 130.6% in 2024, its largest moves.
  • Year by year, Total Liabilities stood at $140.2 million in 2022, then sank by 83.41% to $23.3 million in 2023, then jumped by 130.6% to $53.6 million in 2024, then decreased by 6.91% to $49.9 million in 2025, then advanced by 21.13% to $60.5 million in 2026.
  • Per Business Quant, the three latest OCS Total Liabilities figures stand at $60.5 million (Q1 2026), $49.9 million (Q4 2025), and $46.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 60.46 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 177.22 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 3.79 Bn
4 NuCana 279.75 Bn 279.75 Bn - 7.33 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 7.12 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 9.45 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 15.48 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.62 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 753.82 Mn
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn 4.05 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 60.46 Mn
Dec 31, 2025 49.91 Mn
Sep 30, 2025 46.56 Mn
Jun 30, 2025 46.53 Mn
Mar 31, 2025 46.21 Mn
Dec 31, 2024 53.62 Mn
Sep 30, 2024 35.06 Mn
Jun 30, 2024 28.65 Mn
Mar 31, 2024 22.55 Mn
Dec 31, 2023 23.25 Mn
Sep 30, 2023 26.42 Mn
Jun 30, 2023 19.63 Mn
Dec 31, 2022 140.19 Mn
Dec 31, 2021 129.05 Mn